Head To Head Top Stocks: Trinity Industries, Inc. (NYSE:TRN), Seattle Genetics, Inc. (NASDAQ:SGEN)

u.s stocks , earnings estimates, stock overview, earning reaction history, nasdaq, nyse

Trinity Industries, Inc. (NYSE:TRN)

Trinity Industries, Inc. (NYSE:TRN) closed at $17.32 on the last trading session with an increase of 7.05%, whereas, it previously closed at $16.18. The company has a market capitalization of $2.07 Billion. The company traded shares of 1.88 Million on the trading day while its three month average volume stands at 1.31 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Trinity Industries, Inc. (NYSE:TRN) produced diluted EPS of 1.09. The EPS estimate for next year as estimated by analysts is at 1.2 while EPS for next quarter is estimated at 0.16. Earnings per Share growth for this year is reported at 64.5, while the analysts estimated the EPS growth for next year at 1.2% and Earnings growth for next 5 years stands at 10% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -23.6%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Trinity Industries, Inc. (NYSE:TRN) is at 15.88 while the forward p/e is at 14.49. The P/S or Price to Sales ratio of Trinity Industries, Inc. (NYSE:TRN) stands at 0.69 and Price to Book or P/B for the most recent quarter stands at 1.02. The Price to Free Cash Flow ratio or P/FCF is reported at 9.66. The quick ratio and the current ratio of Trinity Industries, Inc. (NYSE:TRN) are reported at 0 and 0 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Trinity Industries, Inc. (NYSE:TRN) stands at 1.6, 6.4 and 5.1 respectively

The trailing twelve month Revenue of Trinity Industries, Inc. (NYSE:TRN) is reported at 3.01 Billion with income of 139.1 Million. The outstanding shares of Trinity Industries, Inc. (NYSE:TRN) are 119.6 Million. The institutional Ownership of the shares of 98 stands at 0.80%, this figure is increased 2.08 in the last six months. The insider ownership for the shares of Trinity Industries, Inc. (NYSE:TRN) is ticked at 0.3%, the figure is rose 0% in the last six months.

Some other important financial aspects to be discussed here for Trinity Industries, Inc. (NYSE:TRN) is the Mean Target Price estimated by the analysts which stands at 21.26. The 52 week high of Trinity Industries, Inc. (NYSE:TRN) is placed at 24.64 and 52 week low is standing at 15.06.

Performance wise the shares of Trinity Industries, Inc. (NYSE:TRN) rose up 7.58% for the week, it also fell -17.13% for the monthly performance, while for the quarter it went up -24.73%. The shares decrease -9.18% for the half year and plummeted for the Year-To-Date performance. The shares of Trinity Industries, Inc. (NYSE:TRN) shrinked -19.29% for the yearly performance.

Seattle Genetics, Inc. (NASDAQ:SGEN)

Seattle Genetics, Inc. (NASDAQ:SGEN) closed at $105.46 on the last trading session with an increase of 3.52%, whereas, it previously closed at $101.87. The company has a market capitalization of $18.11 Billion. The company traded shares of 1.18 Million on the trading day while its three month average volume stands at 1.14 Million.

Now to discuss some of the Earning per Share estimates and growth estimates, shares of Seattle Genetics, Inc. (NASDAQ:SGEN) produced diluted EPS of -0.97. The EPS estimate for next year as estimated by analysts is at -1.16 while EPS for next quarter is estimated at -0.74. Earnings per Share growth for this year is reported at 32.1, while the analysts estimated the EPS growth for next year at -1.16% and Earnings growth for next 5 years stands at 23% as estimated by the analysts. While Annual EPS Growth rate for past five years as reported by the company is at -9.2%.

Some important ratios are also vital to discuss the performance of the company and its shares. The P/E or Price to Earnings ratio of Seattle Genetics, Inc. (NASDAQ:SGEN) is at 0 while the forward p/e is at 0. The P/S or Price to Sales ratio of Seattle Genetics, Inc. (NASDAQ:SGEN) stands at 19.75 and Price to Book or P/B for the most recent quarter stands at 9.65. The Price to Free Cash Flow ratio or P/FCF is reported at 0. The quick ratio and the current ratio of Seattle Genetics, Inc. (NASDAQ:SGEN) are reported at 4.2 and 4.5 respectively. The Return on Assets ROA, Return On Earnings ROE and ROI Return On Investment for Seattle Genetics, Inc. (NASDAQ:SGEN) stands at -8.5, -10.2 and -11.8 respectively

The trailing twelve month Revenue of Seattle Genetics, Inc. (NASDAQ:SGEN) is reported at 916.7 Million with income of -158700000. The outstanding shares of Seattle Genetics, Inc. (NASDAQ:SGEN) are 171.71 Million. The institutional Ownership of the shares of 0 stands at 0.80%, this figure is increased 3.09 in the last six months. The insider ownership for the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) is ticked at 0.9%, the figure is plummeted -15.47% in the last six months.

Some other important financial aspects to be discussed here for Seattle Genetics, Inc. (NASDAQ:SGEN) is the Mean Target Price estimated by the analysts which stands at 125.75. The 52 week high of Seattle Genetics, Inc. (NASDAQ:SGEN) is placed at 124.32 and 52 week low is standing at 62.90.

Performance wise the shares of Seattle Genetics, Inc. (NASDAQ:SGEN) rose up 10.03% for the week, it also fell -6.16% for the monthly performance, while for the quarter it went up -8.42%. The shares increase 43.07% for the half year and plummeted for the Year-To-Date performance. The shares of Seattle Genetics, Inc. (NASDAQ:SGEN) grew 40.07% for the yearly performance.